in 13 patients with maturity-onset diabetes mellitus which did not respond to diet therapy alone , serum concentration of glipizide , blood glucose ( b-g ) concentration , serum immunoreactive insulin ( s-iri ) and plasma glycerol ( p-g ) were monitored hourly over 12 hours after placebo , an initial dose of glipizide ( 5 mg p.o . ) and long-term treatment with glipizide ( range 7.5 -- 20 mg , mean 10.4 ) , which produced fasting b-g of less than 8 mmol/l .
C0011860
maturity-onset diabetes mellitus
C0017642
glipizide